 | Arbutus Biopharma Corporation | |||
| NMS : ABUS || Location: United States | ||||
$2.73+0.01 (+0.44%) |
0.17 M | 2.71 - 2.77 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 5.171 M |
| March 28, 2024 | 4.546 M |
| March 15, 2024 | 4.129 M |
| Feb. 29, 2024 | 4.066 M |
| Feb. 15, 2024 | 3.692 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.12 | -0.12 | 0.33% |
| 09/30/2023 | -0.12 | -0.12 | -3.36% |
| 06/30/2023 | -0.11 | -0.10 | 12.59% |
| 03/31/2023 | -0.14 | -0.10 | 27.90% |
| 12/31/2022 | -0.14 | -0.14 | -3.11% |
ABUS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 180.175M | Shares Float | 115.805M |
| Short Float | 5.171M | Market Cap | 490.08M |
| Institution ownership | 43.46% | Insider ownership | 23.344% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.44 | Forward EPS | -0.53 |